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MRI is becoming increasingly important in the characterization of NAFLD,
which is one of the most relevant diffuse liver diseases with increasing preva-
lence in the developed countries. Currently, biopsy is the gold standard in the
early identification and staging of NAFLD, which is crucial to evaluate the risk
of hepatocellular carcinoma development. However, the later is associated with
sampling errors and with the development of several post-surgical complica-
tions. In this work, we address the problem of quantifying the fat accumulation
in the liver using a non-invasive procedure based on chemical shift imaging and
two signal models, the magnitude and complex models. In particular, we ad-
dress the influence of noise, relaxation effects and choice of echo times in fat
fraction estimation error. Our approach relied in the development of a new
acquisition strategy based on the optimal choice of echo times, which were
evaluated in simulation studies and later tested with phantoms. A program to
perform in-vivo fat quantification was implemented, extending our approach to
clinical data. Results indicate that good fat fraction estimation can be achieved
by correctly choosing the echo times. However, it is extremely difficult to find a
single echo time combination which optimize a large range of fat fractions. Fi-
nally, we also demonstrate that the standard clinical protocol has several flaws
and that a new acquisition protocol must be developed.
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Chapter 1
Introduction
1.1 Motivation and objectives
The western life style keeps on changing: obesity and problems that emerge
from fat accumulation are a well-known issue nowadays. Public and private
health institutions, governmental associations and even the media have been
promoting awareness campaigns aiming to minimize and prevent what can be
seen as a public health problem. An increasing topic of interest is, therefore, fat
accumulation in the liver, which gives rise to Non Alcoholic Fatty Liver Disease
(NAFLD). NAFLD is a diffuse liver disease which is not related to alcohol
consumption, but rather linked to the metabolic syndrome [1]. It comprises
a spectrum of clinical conditions of increasing severity that range from simple
steatosis to non-alcoholic steato-hepatitis (NASH), fibrosis, and finally cirrhosis
[1, 2].
The characterization and staging of NAFLD is increasingly important since
several studies recognize NAFLD as the most common cause of chronic liver
disease with a high prevalence worldwide, particularly in the western world.
Currently, liver biopsy is the gold standard in early assessment of NAFLD.
However, the latter is an invasive and expensive method prone to sampling
errors and low accuracy [1–3].
With the evolution of technology and the increased interest on biomedicine,
magnetic resonance (MR) chemical shift methods appeared as non-invasive al-
ternative to biopsy in the early characterization and staging of NAFLD. The
1
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idea was simple but very effective; take advantage of the difference in the res-
onance frequency between the protons of water and fat, a property known as
chemical shift, to quantify the amount of fat present in the liver [4]. MR spec-
troscopy (MRS), which takes advantage of the chemical shift effect to detect
and quantify various chemical species, led to several advances in quantitative fat
estimation and it is now considered the safest and most accurate non-invasive
method. However, MRS is performed on a single-voxel basis, thus introducing
variability at the same time that is time consuming and therefore not suitable
for normal clinical routine [5, 6]. In contrast, chemical shift imaging emerges as
an attractive method for fat quantification on a voxel-by-voxel basis since it al-
lows for whole-liver coverage, it is widely accessible and easy to use. In fact, it is
well established in the literature that if the signals from water and fat protons
were correctly separated, accurate fat quantification would be possible [4–6].
Nevertheless, the correct mathematical modulation of the signal, the noise, the
relaxation effects as well as the errors introduced by external magnetic field in-
homogeneities are confounding factors in fat quantification, introducing errors
in the estimates [4, 7].
Although, many advances were made regarding fat quantification with chemical
shift imaging, there are still many methodological questions that remain open.
Particularly, the properly evaluation and addressing of the echo times, that are
used to sample de data during the several scans that are acquired at multiple
echo times.
The present work, which aims to optimize fat quantification in the liver using
chemical shift imaging, consists of three main parts: the first one is a simulation
study where the accuracy of several signal models are tested with respect to
liver fat fraction quantification at 3T, In particular, the influence on fat fraction
bias and error of sampling the signal with different echo times combinations,
will be explored. The second part consists in identifying the echo time combina-
tions that minimize both fat fraction bias and error. Subsequently, appropriate
phantoms will be built in order to test experimentally the results obtained in
the simulation study. Finally, the third part of this work consists in developing
a software to produce parametric maps of liver fat fraction based on clinical
data.
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1.2 Theoretical background
1.2.1 The liver: a brief overview
The liver (figure 1.1) is the largest internal organ weighting approximately 1.3Kg
to 1.7Kg. It is located in the upper right quadrant of the abdominal cavity under
the right hemidiaphragm; lying to the right of the stomach and overlying the
gallbladder [8, 9]. At the anatomic level, four lobes can be identified: the left,
right, caudate and quadrate lobes [9]. The lobes are than divided in lobules
which are the functional units of the liver, containing the hepatic cells [8, 10].
The liver is also connected to two major afferent blood vessels, the hepatic artery
and the portal vein, by which it gets its blood supplies. These vessels branch
themselves into minor vessels, forming the capillary network, which reaches the
lobules and intervene in the liver functions [8, 9].
Figure 1.1: The Liver: general anatomy and location. Source: aviva.com.uk, medical encyclopae-
dia
The epithelial cell population consists of the hepatocytes (parenchymal cells)
and the cholangiocytes, which are the two main cell types in the lobules. The
hepatocytes correspond to approximately 80% of the livers volume and are the
key effectors in its activity [10]. However, this convention is somewhat wrong.
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In fact, together with the hepatocytes, several other cells work as an integrated
community to carry-out the liver functions. This functional integration is ob-
tained by several communication mechanisms, such as signalling networks [10].
As far as physiological functions are concerned, the liver has a well-established
role in several functions:
1) Digestion: Due to its secretory function, the liver can be considered
a gland. The hepatocytes produce and excrete the bile, a fluid that is
storaged in the gallbladder and delivered into the small intestine. The bile
aides in the digestion of fat and in the absorption of fat soluble nutrients
[10, 11].
2) Metabolism: The liver is involved in several metabolic processes. For
example, it regulates the levels of glucose in the blood flow as well as the
storage of fat. The production, metabolism and excretion of cholesterol
is also controlled by the liver [10, 11].
3) Storage: The liver stores several nutrients such as vitamins A, B-9 and
D. Furthermore it also stores iron, which can be used to form heme groups,
such as the ones present in hemoglobin [10, 11].
4) Detoxification: The liver plays a major role in helping the organism
metabolizing toxic substances that have been absorbed. Substances like
alcohol, drugs, pesticides, and heavy metals which are absorbed in the
digestion are delivered into the liver through the portal vein. The liver
filters and processes these substances, and excretes them to the bile. Nor-
mal bio products of the metabolism are also metabolized by the liver
[10].
5) Protein synthesis: The liver is involved in the synthesis of several pro-
teins, including enzymes and hormones [10, 11].
1.2.2 Non Alcoholic Fatty Liver Diseases
Normal liver activity can be affected by several factors which can lead to severe
health issues.NAFLD is an heterogeneous liver pathology that is not linked to
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alcohol consumption, but rather to the metabolic syndrome [1]. NAFLD com-
prises a vast spectrum of pathologies of increasing severity and that range from
fat accumulation inside the hepatocytes (steatosis) to non-alcoholic steatohep-
atitis (NASH), that lead to fibrosis and cirrhosis (figure 1.2) [1–3, 12].
Figure 1.2: Stages of NAFLD and corresponding histological appearance. Adapted from [13].
The first stage of NAFLD is the simple accumulation of fat droplets within
the hepatocytes, a condition known as steatosis [3, 12]. In order for a subject
to be classified as having steatosis, fat accumulation in the liver must exceed
5% to 10% by weight [1, 2]. Steatosis in itself is not associated with increased
short-term morbidity nor mortality. However, it can trigger the progression to
more severe stages of NAFLD such as NASH [2, 12, 14]. The mechanisms by
which this triggering takes place are still largely unknown, but it is believed
that fat accumulation increases the probability of cell injury [1].
NASH is characterized by excessive fat accumulation combined with liver cell
injury, inflammation and necrotic activity [1, 2, 14]. It is correlated both with
morbidity and mortality, and it is increasingly becoming a reason for liver trans-
plantation [14]. In addition, NASH dramatically increases the risk of fibrosis,
cirrhosis, liver failure and hepatocellular carcinoma (HCC) [1, 12]. In the last
two stages of NAFLD, there is the replacement of liver tissue by fibrotic tissue,
with the loss of lobular architecture and severe cell injury. At these stages,
patients are at a higher risk of developing HCC [2].
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1.2.2.1 Pathogenesis
The exact pathogenesis of NAFLD remains poorly understood. However, it
is widely considered to be the manifestation of the metabolic syndrome, i.e.
related to Diabetes Mellitus Type 2, insulin resistance and obesity [1, 14].
The most widely accepted explanation for NAFLD pathogenesis is the multi-
hit hypothesis. In this hypothesis, multiple hits are in the origin of the disease
and its progression, with the metabolic syndrome playing a central role [14].
Insulin resistance is associated with fat retention, which makes it closely related
to obesity, and is considered to play a major role in NAFLD pathogenesis
[2, 14, 15].
1.2.2.2 Epidemiology
Recent studies recognize NAFLD as the most common cause of chronic liver
diseases [1, 14, 16, 17]. Although, geographic variations in its prevalence are
notorious, NAFLD affects all racial and ethnic groups as well as ages and genres
[18] and it has been reported worldwide with a distribution that is closely asso-
ciated with diabetes and obesity [14, 18]. The latter conditions are now reaching
epidemic proportions, particularly obesity, and serve as a good overview for the
incidence of NAFLD as figure 1.3 shows. Furthermore, NAFLD prevalence is
increasing, particularly in the western world [14, 18].
Figure 1.3: Estimated worldwide prevalence of obesity in males and females aged above 15 in
2010. Source: WHO [14]
A number of studies indicate that, only in the United States of America, 30%
of the general population is affected. The same reports estimate an incidence of
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10% to 30% on the world population [16, 17]. The prevalence among children
is pointed to be up to 10% overall, being that the incidence in obese children is
even more severe and reported to be up to 53% [19]. Although Gastadelli et al,
2007, report that 80% to 90% of the identified cases rely on simple steatosis,
Falck-Ytter et al, 2011, showed that up to 20% of patients with steatosis develop
NASH and cirrhosis [19, 20]. Moreover, according to new data presented in the
International Liver Congress of 2011, the prevalence of NAFLD is expected to
increase, in the USA alone, by 50% in 2030, thus reaching epidemic proportions.
1.2.2.3 Diagnosis
As previously shown, the worldwide prevalence of NAFLD is large, which im-
plies that its diagnosis and early assessment are extremely important. As a
consequence, several studies using various medical imaging techniques, have
been proposed to help in the early diagnosis and assessment of NAFLD.
Ultrasound imaging detects fat accumulation in the liver. However, it cannot
quantify fat and subsequently differentiate between stages, therefore it often
requires further evaluation with other techniques, such as biopsy [3]. Liver
biopsy is currently the gold standard in NAFLD early assessment [1, 2, 12, 14].
However, this technique presents several drawbacks, the most important of
which are the high cost, potential post-surgical complications, and inherent
sampling bias. The latter is very important for the correct diagnose based
on biopsy, since fat infiltrations are heterogeneously distributed while biopsy
only samples one or few liver portions. Finally, hepatic biopsy is a highly
invasive procedure with risk of morbidity and even mortality: about 1% to 3%
of the patients require hospitalization and the complications may vary with the
procedure [21].
1.2.3 MRI fundamentals
MRI is a medical image technique based on the interaction of nuclear spins
(protons in the hydrogen atoms of water molecules) with an external magnetic
field, B0 [22–25]. Due to its abundance in the human body,
1H nuclei are
typically used in MRI to produce images with various types of contrast [22, 23].
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The generation of signal to produce images is based on the manipulation and
detection of the magnetization that is available in the sample [22–24].
In the absence of B0, each spin ensemble element (with individual magnetic
moment (~µ) of equal magnitude) is randomly oriented. As a consequence,
the resulting net magnetization is zero. In the presence of B0, the magnetic
moments tend to align with the direction of B0 in two orientations: parallel and
anti-parallel to B0. At room temperature there is small excess of spins aligned
parallel to B0 which produce the net equilibrium, ~M0 [22, 23]. Furthermore,
the spin precesses around the axis defined by the direction of B0 at a constant
(Larmor) frequency [22] which is given by the Larmor equation
ω0 = γB0 (1.1)
where γ is the gyromagnetic ratio.
In the absence of any other magnetic field, the net magnetization ( ~M) remains
at equilibrium, i.e. aligned parallel to the direction of B0, and no signal is gen-
erated. In order to produce an MR image, the magnetization has to be excited
away from its equilibrium position. This is accomplished by the application of
a radiofrequency (RF) pulse (B1) that is applied to the system orthogonally to
B0, for a short period [22, 23]. If the sample is irradiated with an RF pulse
with frequency (ωRF = ω0 (on resonance condition)), the spins absorb the RF
energy, thereby causing the net magnetization, ~M , to move away from its origi-
nal equilibrium position and to rotate around an axis perpendicular to both B0
and B1 (figure 1.4) [22]. Following RF excitation, ~M will have a longitudinal
component ~Mz, parallel to B0, and a transverse component ~Mt, perpendicu-
lar to B0, which will continue precessing around B0 at the Larmor frequency
[22, 23]. The variation in ~Mt generates an RF signal which is detected with a
coil by magnetic induction and that is used for image reconstruction [22–25].
1.2.3.1 Relaxation effects and Bloch equation
Relaxation effects
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Figure 1.4: The application of an RF pulse, B1, along the direction of x causes ~M to rotate in
the direction of y (Left). Precession movement in the xy plane (right) [25].
After excitation, and in the absence of any other RF pulse, the spins release
the absorbed energy and ~M returns progressively to equilibrium. This process
is called relaxation and it is governed by two time constants: T1 and T2 [22–25].
During T1 relaxation or spin-lattice relaxation, the spins release their energy
to the surrounding atomic lattice. As a consequence, ~Mz returns progressively
to its equilibrium value. The rate at which spin-lattice relaxation takes place
is controlled by the T1 relaxation time constant. Generally, T1 times are in
the order of several hundreds of milliseconds and vary from tissue to tissue as
well as with the intensity of B0 [23–25]. The T2 relaxation time, also called
spin-spin relaxation, is associated with the transverse decay of ~M [22, 23].
Spins experience local fields produced by the surrounding protons. This leads
to different local precessional frequencies and subsequently to the loss of phase
coherence or dephasing, as figure 1.5 illustrates. Dephasing decreases transverse
magnetization and reduces signal intensity [22, 23].
The presence of spatially varying inhomogeneities in B0 are also responsible for
the dephasing of transverse magnetization. This type of relaxation is controlled
by the T ′2 relaxation time constant [22, 25]. Thus, the total transverse relaxation
is the summed effect of spin-spin interaction and magnetic field inhomogeneities,
and it is characterized by the T ∗2 relaxation time constant, defined as
1
T ∗2
=
1
T ′2
+
1
T2
(1.2)
The values of T2 and T
∗
2 , which are in the order of the milliseconds, vary from
tissue to tissue and are dependent of the strength of the applied B0; overall,
T1 > T2 > T
∗
2 [22].
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Figure 1.5: Dephasing of spins in the transverse plane due to T2 relaxation (above) and its
influence on the net magnetization intensity (below)[22].
Bloch Equations in the absence of B1
The Bloch equations [22] describe the magnetization in presence of B0, B1 and
relaxation effects as
dMz
dt
= −ω1My + M0 −Mz
T1
(1.3)
dMx
dt
= ∆ωMy − Mx
T2
(1.4)
dMy
dt
= −∆ωMx + ω1Mz − My
T2
(1.5)
where M0 is the value of the equilibrium magnetization, ω1 is the spin frequency
due to the RF field and Mz , Mx and My are the magnetization components
along x-, y-, and z-axis respectively. ∆ω represents the difference between ω0
and ω, where ω is the RF pulse frequency. It is furthermore assumed, without
loss of generality, that B0 is oriented along the z-axis and that Mz and Mx(My)
are the longitudinal and transverse components of ~M respectively. B1 is also
considered to be much smaller than B0 [22].
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When only B0 and relaxations effects are considered, equations 1.3, 1.4 and 1.5
are written as
dMz
dt
=
M0 −Mz
T1
(1.6)
dMx
dt
= ω0My − Mx
T2
(1.7)
dMy
dt
= −ω0M − My
T2
(1.8)
Solving for 1.6, the following solution is obtained:
Mz(t) = Mz(0)e
−t/T1 +M0(1− e−t/T1) (1.9)
This expression quantifies T1 relaxation, i.e. it shows the evolution from the
initial magnetization value after excitation, Mz(0), to the equilibrium value M0
[22]. The solution to 1.7 and 1.8 is
Mx(t) = e
−t/T2(Mx(0)cosω0t+My(0)sinω0t) (1.10)
My(t) = e
−t/T2(My(0)cosω0t−Mx(0)sinω0t) (1.11)
Which corresponds to the T2 exponential decay of the transverse magnetization
that is precessing around B0 (z-axis) with an angular frequency ω0 [22].
1.2.3.2 Spatial encoding
The goal of MRI is the spatial localization of MR signals in order to be able to
reconstruct an image. Spatial encoding of the MR signal in three dimensions
is obtained by applying magnetic field gradients in three different directions.
These gradients produce a signal with spatially varying frequency components
in accordance with
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ω(x) = γB(x) (1.12)
Where x is the spatial coordinate along the direction of the gradient and B(x)
is the magnetic field that spins, at position x along the gradient direction,
experience [22].
Three main gradients are used to perform spatial encoding: Slice selection
(Gss); Phase encoding (Gpe) and Readout or Frequency encoding gradient
(Gro) [23–25].
The first step in spatial encoding is the selection of a slice plane to be imaged.
Two main components are involved in this process: the selective RF pulse and
Gss. The selective RF pulse has a limited bandwidth of frequencies which are
related to slice thickness. When this pulse is applied in the presence of Gss, a
portion of the sample, coincident with the desired slice location and thickness, is
excited [23, 24]. During phase encoding, Gpe induces a constant spin dephasing
along the direction of Gpe. As a consequence, spins at different positions along
that direction will precess at the same frequency but with different phases.
Thus, phase encoding locates the MR signal along Gpe direction through spin
phase variation [23, 24]. Finally, the effect of Gro is to cause a variation of the
spin precession frequency along its direction. This frequency variation encodes
the third spatial coordinate and allows for image reconstruction using Fourier
Transformation [23–25].
1.2.3.3 Pulse sequences
Pulse sequences are the methodology by which an MRI image is acquired, and
involve the manipulation of e.g. RF pulses, gradients analog-to-digital con-
version (ADC), which are usually applied with a fixed pre-determined order
− pulse sequences [23]. Several parameters are important in pulse sequences,
namely the repetition time (TR), the echo time (TE) and flip angle (α). The
TR corresponds to the time between successive excitation RF pulses whereas
α is the angle by which the magnetization is tipped away relative to the B0
direction by the application of the RF pulse. Finally, TE is defined as the time
from the excitation pulse to the time point where maximum signal is detected
[23].
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There are two main families of pulse sequences: Spin-echo (SE) and Gradient-
echo (GRE) sequences [22, 23].
Spin-echo sequences are the most commonly used in clinical procedures. This
technique is characterized by the use of, at least, two RF pulse: an RF excitation
pulse, generally with a flip angle of 90o, and one (or more) 180o refocusing pulse,
which is applied to rephase the signal and to generate a spin-echo. If more than
a spin-echo is desired, then several 180o refocusing pulses are necessary [23].
The second type of pulse sequences are the gradient-echo sequences. In contrast
to spin-echo sequences, these sequences do not use RF refocusing pulses. Gra-
dient reversal is used instead for magnetization rephasing and signal generation
the gradient-echoes. Another difference with respect to SE sequences is that
flip angles lower than 90o are generally used. Furthermore, GRE sequences are
typically weighted on T ∗2 [22, 23]. In this work, the pulse sequence that is used
for data acquisition is of the GRE type.
Figure 1.6: Spoiled GRE sequence timing diagram, 2D method. Because there is no 180o RF
pulse, the polarity of Gro dephasing gradient pulse (a) is opposite that of the readout gradient
pulse applied during signal detection. The TE is measure from the middle of the excitation to the
center of the echo [25].
1.2.3.4 Chemical shift imaging
The precession frequency of spins depends on the local magnetic field that each
individual spin experiences. So far, it was assumed that only B0 contributes
to this local magnetic field. However, in reality each spin has its own local
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magnetic field, which is determined by which molecules and atoms exist in the
neighbourhood of the spin [22, 23, 25].
In MRI, the signal comes essentially from the protons in water molecules and in
the chains of fatty acids [22, 23, 25]. Protons from water and fatty acids experi-
ence different chemical environments and have distinct electron configurations,
as figure 1.7 shows [25].
Figure 1.7: Chemical environment of water (left) and fat protons with the shading regions illus-
trating the electron density distribution [25].
Because of its molecular environment, the water proton experiences a local
magnetic field which is different from that of a fat proton. This local difference
is known as chemical shielding and leads to slightly different Larmor frequencies,
for water and fat [22, 23, 25]. Such frequencies can be described in terms of
chemical shifts, σ, which is defined as
Bshifted(j) = (1− σj)B0 (1.13)
Where Bshifted is the the local magnetic field difference and j represents the
chemical compound, which in the present work is fat. The chemical shift term
is generally small and it is expressed in parts-per-million (ppm) with a value of
3.5 for fat (figure 1.8) [22, 23]. The difference in the Larmor frequency from fat
relative to water depends also on B0 and is given by
∆ω0 = γσB0 (1.14)
where for B0 = 3T the chemical effect is approximately equal to 450Hz [23].
This difference in frequencies causes the fat protons to precess slower than the
water protons. As a consequence, the water and fat magnetization components
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Figure 1.8: Spectrum of water and fat at 3T. The resonance frequencies are separated by 3.5ppm
which corresponds to a frequency difference of 450HZ [23].
are in phase and out of phase (oppose-phase), depending of the TEs, as illustrate
in figure 1.9 [22, 23].
Figure 1.9: Precession of fat and water protons. Due to the difference in the resonance frequencies,
the two components are in phase (a, c and e) and out of phase (b and d) at distinct TEs [23].
In the SE sequences, the chemical shift effect is compensated by the 180o RF
refocusing pulse which implies that water and fat protons are always in-phase.
In GRE sequences there is no compensation and therefore both chemical species
acquire phase with respect to each other that is proportional to TE. In a voxel
containing water and fat, when both components are in-phase, a reinforcement
of the signal is observed. when both components are out-of-phase there is signal
cancelation as illustrated in figure 1.10 [22, 23].
Chapter 1. Introduction 16
Figure 1.10: In-phase (A and C) and opposed-phase (B and D) abdominal images acquired using
a GRE sequence. Arrows indicating the phase cancelation in voxels containing water and fat.
Chemical shift imaging takes advantage of the abovementioned properties and
it is referred as the process by which identical nuclei, experiencing different
levels of shielding, are selectively imaged [22].
1.2.4 NAFLD and chemical shift imaging
Since Dixon (1984) first proposed the two-points Dixon technique to decompose
the water and fat components based on two images (in-phase and opposed-
phase) [26], many advances on chemical shift imaging for fat quantification were
made. Two main models have been used to separate water and fat components
with multi-echo (ME) sequences: magnitude and complex models [4, 27–29].
These models rely on the acquired data to perform an water/fat decomposition
using a least-squares fitting procedure[30]. A few clinical applications of the
magnitude model [5, 6, 31–37] and, to a lesser extent of the complex model
[34, 37, 38] have proved these methods to be suitable alternatives for non-
invasive in-vivo fat quantification. However, several methodological issues have
largely been misunderstood [4, 7].
There are small spatial variations in the main magnetic field of an MR scanner,
known as magnetic field inhomogeneities [4, 39–41]. They depend not only on
hardware issues, but also on the sample that is being imaged. Magnetic field
inhomogeneities, together with the chemical shift, influence the phase of the
signal, introducing unexpected phase errors which can potentially increase the
systematic errors associated with parameter estimation [4, 39]. Furthermore,
such inhomogeneities tend to increase with the intensity of the main magnetic
field, which implies that ultra-high field scanners (B0 > 3 tesla (T)) are more
susceptible to this problem. Although phase errors due to magnetic field in-
homogeneities had been addressed, they are not, yet, well quantified [39]. The
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complex model is very sensitive to this problem, since it takes phase informa-
tion into consideration when estimating fat content. Magnitude model considers
only magnitude data (discarding all phase information) and emerges as a simpli-
fied model that overcomes the estimation errors associated with magnetic field
inhomogeneities [4, 27–29, 34]. Nevertheless, the latter model is characterized
by inherent noise amplification. This, together with the fact that it contains
no phase information implies that it is often unable to accurately estimate fat
fractions over 50% [4, 37].
The influence of the relaxation effects (T1 and T
∗
2 ) is another confounding factor.
Many studies discuss that the way that the relaxations are implemented in the
models have a strong influence in the quantification, namely the T ∗2 . It is
well documented in the literature that when T ∗2 relaxation is ignored, highly
biased estimations are obtained whereas in the presence of T ∗2 corrections the
estimation is enhanced [7, 31]. Generally, two assumptions are made regarding
T ∗2 relaxation constants:
1) Consider two independent T ∗2 constants for water and fat [7, 39, 42];
2) Assume only a common T ∗2 relaxation constant for both components [35,
40].
In certain conditions, the use of a single T ∗2 constant can improve fat quantifica-
tion and avoid large errors [4, 27]. For instance, in advanced stages of NAFLD
it is common to find iron overload in 40% of the patients [43, 44]. This shortens
the values of T ∗2 leading to a much larger error in their estimation . Modelling
the signal with only one T ∗2 relaxation constant is reported to be a way to
surpass this situation [7, 36]. However, Chebrolu et al. (2010) questioned the
validity of the assumption that T ∗2 of fat and water may be equal, given that
there is no biological evidence in support of this statement. The same article in-
dicates that for values of T ∗2 that are significantly different, larger errors emerge,
especially when T ∗2 of fat and water are short [7]. In addition, it is known that
spurious T1−weighting images leads to an overestimation of fat since T1 of fat
is shorter than that for water; nevertheless, a way to overcome this problem is
using small flip angles or dual flip angles during the acquisition [45].
In order to enhance fat quantification, some methodological improvements were
proposed in recent years. A number of groups introduced MRS fat peaks when
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modelling the signal [29, 30]. Hernando et al.(2012) proposed the mix-approach
model in which the best of magnitude and complex models was taken into ac-
count. Although, good estimations were achieved by this model, phase errors
remain a problem [34]. Finally, Heredita et al. (2012) developed a new method-
ology based on the analysis of liver-vessel cancelation artefact on in-phase and
oppose-phase MRI images. This methodology shows that the presence of phase
cancelation around the intra-hepatic vessels is a feature of ultra-high fat ac-
cumulation. However, phase cancelation is not observed in low values of fat
content which implies that this approach is not complete in estimating a large
range of fat accumulation [33].
Despite the advances in fat quantification based on chemical shift imaging,
many issues remain quite unexplored. An important methodological issue is
the choice of the TE combination to be used in data sampling. The latter is
often empirical, and its impact in fat quantification with both the magnitude
and complex models, remains to a large extent unknown [37]. Furthermore, the
majority of chemical shift fat quantification procedures require accuracy evalu-
ation by means of other techniques such MRS, which is particularly undesirable
in clinical procedures [5, 6, 28, 29, 32].
Chapter 2
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2.1 Signal models for fat quantification
Chemical shift imaging relies on the fact that hydrogen protons in water and fat
molecules have different resonance frequencies. This technique uses the distinct
water-fat phase shifts, generated at multiple echo times, to estimate the water
and fat content in tissues on a voxel-by-voxel basis [37]. In general, voxels may
contain different amounts of water and fat, as figure 2.1 suggests.
Each fat and water component generates signal with a given intensity. If signal
intensity from both components can be sorted out correctly, then the precise
amount of fat fraction, FF, can be calculated as
FF =
Sf
Sw + Sf
(2.1)
where Sw and Sf are the signal intensities from water and fat, respectively [27].
In order to estimate Sw and Sf , the signal from each voxel must be described
by a suitable mathematical model. There are several factors to be taken into
account when modelling the voxel signal:
1) A fundamental assumption of FF estimation is that water and fat are the
only two signal-contributing chemical species [40];
19
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Figure 2.1: Schematic representation of a sample with voxels containing different amounts of
water and fat.
2) Water and fat protons have different T ∗2 relaxation constants, which im-
plies that the models must consider the signal intensity decay over time
due to these constants [4];
3) Magnetic field inhomogeneities influence the signal phase and should also
be considered when modelling the signal [4].
Several models have been proposed to describe the signal in chemical shift
imaging. In the present study, the magnitude model and complex model are
addressed.
2.1.1 Magnitude and complex models
A model vastly discussed in the literature is the estimation of fat from mag-
nitude images. In this model, the magnitude of the total signal |S| from any
given voxel can be modelled as the sum of the signals from both water and fat
components
|S| =
∣∣∣Swe−TE/T ∗2w + Sfe−TE/T ∗2f ei∆ωTE∣∣∣ (2.2)
Where TE represents the echo time, Sw (T
∗
2w) and Sf (T
∗
2f ) are the signal inten-
sities (T ∗2 relaxation constants) from water and fat respectively [28]. Parameter
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∆ω is the phase angle due to the chemical shift effect and it is given, in radians,
by
∆ω = 2piγσB0 (2.3)
Here, γ represents the gyromagnetic ratio, σ is the chemical shift between fat
and water and B0 is the external magnetic field intensity [40].
If MR complex data is considered for fat quantification, i.e. if in addition to
magnitude images, the phase information is also taken into account, then data
modelling is slightly modified, when compared to 2.2. In this case, the signal
from a voxel with water and fat, including the effects of T ∗2 relaxation, chemical
shift and magnetic field inhomogeneities, can be modelled as
S =
[
Swe
−TE/T ∗2w + Sfe
−TE/T ∗2f ei∆ωTE
]
ei∆ω0TE (2.4)
where all constants are as defined in 2.2 [7]. Parameter ∆ω0 = 2piγ∆B0 is the
frequency shift due to magnetic field inhomogeneities, ∆B0. The corresponding
phase accumulation is then defined as φ = ∆ω0TE [40].
Magnitude and complex models can be implemented by considering that the
T ∗2 relaxation constants of water and fat are different (dual-decay model) or
by assuming the simplifying assumption that T ∗2w = T
∗
2f (single-decay model)
[4, 35, 41]. In the latter case, equations 2.2 and 2.4 simplify to
|S| = ∣∣(Sw + Sfei∆ωTE)e−TE/T ∗2 ∣∣ (2.5)
S =
(
Sw + Sfe
i∆ωTE
)
e−TE/T
∗
2 ei∆ω0TE (2.6)
2.2 Theoretical and experimental work
2.2.1 Simulation studies
Simulations were conducted (for both single- and dual-decay models) to:
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1) Determine the influence of different combinations of TE values in the
estimation bias and error of FF, T ∗2w, and T
∗
2f in the presence of noise and
using both magnitude and complex models;
2) Complex model: Determine the influence of phase errors due to magnetic
field inhomogeneities in estimation bias of FF, T ∗2w, and T
∗
2f ;
3) Complex model: In the presence of noise and phase errors, study the
variation of estimation bias and error with different combinations of TE
values.
Data was simulated considering T ∗2w =23.8ms, T
∗
2f=18.5ms [4] and FF = 5%,
25%, 50% and 75%. Rician and Gaussian noise were added to magnitude and
complex data respectively with relative noise amplitude (RNA) of 5% and 10%.
Noise amplitude, NA, was calculated from the value of RNA according to
NA = max
[
S0w
S0f
]
RNA (2.7)
where S0w and S0f are the signal intensities for water and fat respectively,
considering B0 = 0.
Computations were conducted using software that was written in Matlab R2012a
(Mathworks, Natick, Mass). The Levenberg-Marquart method (lsqnolin func-
tion in Matlab) was chosen for the non-linear fit (in a least-squares sense) of
FF, T ∗2w, and T
∗
2f to the data.
2.2.1.1 Noise studies
Monte Carlo simulations were conducted to evaluate the robustness of mag-
nitude and complex models, in the presence of noise, for different combina-
tions of TE values. Sample data was simulated at twelve different TEs at 3T.
Each Monte Carlo simulation took 1000 different noise realizations into ac-
count. Noise realizations were extracted from a Rician distribution (in the case
of magnitude data) and from a Gaussian distribution (in the case of complex
data).
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Figure 2.2: flowchart illustrating the major steps of the algorithm that was implemented to
evaluate the behaviour of the models in the presence of noise.
The efficiency of each model to determine the FF was quantified using the
number of signal averages (NSA) which is defined as
NSA =
√
σ
σE
(2.8)
Where σ represents the noise standard deviation and σE is the standard devi-
ation associated with the estimation of Sf .
Besides NSA, two other measures were used to evaluate the models: Bias and
Error. The Bias associated with a given parameter X is defined as
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BiasX =
X¯E −Xt
Xt
× 100 (2.9)
Where X¯E is the mean of the estimates XE of all noise realizations, and Xt
is the true value of X. The bias of a given estimated parameter quantifies
the error in parameter estimation due to the incompleteness of the model to
describe the data. On the other hand, Error X reflects the error in parameter
estimation which results from the sensitivity of the model to noise. It is defined
as
ErrorX =
σXE
X
× 100 (2.10)
Where σXE is the standard deviation associated with XE.
The biases and errors were computed for FF, T ∗2w and T
∗
2f . Results were rep-
resented as colour maps with the NSA, bias an errors expressed as function of
TEmin (TE minimum) and ∆TE (step between TEs). The flowchart in figure
2.2 illustrates the major steps that were implemented in the algorithm for noise
simulations.
2.2.1.2 Influence of magnetic field inhomogeneities and noise on FF
estimation using complex model
Model parameters were estimated for both single- and dual-decay models, with-
out noise, at 400 different off-resonance frequencies, ranging from -200Hz to
200Hz and considering FFs of 5%, 25%, 50% and 75%. The simulations were
performed for three distinct TE combinations: the clinical protocol and two
TEs combinations that were chosen from the identification of TE-∆TE regions
where both the bias and errors (in FF, T ∗2w and T
∗
2f ) were minimized in the pres-
ence of noise (for single- and dual-decay models). All the remaining simulation
parameters were equal to what was previously described.
Echo times :
1) Single-decay model: TEs of 3,00ms to 27,20ms in increasing steps of
2,20ms;
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2) Dual-decay model: TEs of 2,80ms to 28,10ms in increasing steps of 2,30ms;
3) Clinical protocol: TEs of 2,46ms to 15,99ms in increasing steps of 1.23ms.
The biases in FF, T ∗2w and T
∗
2f were obtained as function of off-resonance fre-
quencies. The flowchart presented in figure 2.3 shows the algorithm that was
implemented.
Figure 2.3: Flowchart illustrating the major steps of the algorithm that was implemented evaluate
the influence of off-resonance frequencies on complex model FF estimations.
In order to evaluate the combined influence of noise and magnetic field inho-
mogeneities on FF estimation (with single- and dual-decay constants), a set of
simulations, similar to those described above were computed. For each simula-
tion, the TEmin was kept fixed and equal to those indicated above. Estimation
Bias and Error were plotted as colour maps as function of off-resonance fre-
quencies and ∆TE. Figure 2.4 shows the flowchart of the algorithm that was
implemented for these computations.
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Figure 2.4: Flowchart illustrating the major steps of the algorithm that was implemented to
evaluate the influence of noise and off-resonance frequencies on complex model FF estimations.
2.2.2 Fat quantification program
A program with a basic user interface was implemented in order to estimate
FF, on a voxel-by-voxel basis, from in-vivo multi-echo gradient-echo (ME-GRE)
data. In addition to FF, estimations for T ∗2w and T
∗
2f can also be obtained.
Results are obtained as parametric maps that are represented on the original
dicom images (i.e. a voxel in a dicom image correspond to the same voxel in
a parametric map). The flowchart in figure 2.5 indicates the major steps that
are involved in the implementation of this program.
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Figure 2.5: Flowchart illustrating the major steps of the algorithm that was implemented to
estimate the FF on a voxel-by-voxel basis.
2.2.3 Experimental work
2.2.3.1 Phantom construction
In order to experimentally validate the simulation results, a phantom consisting
of 6 vials, containing a water-fat emulsion with different values of FF, was built.
In order to minimize image artefacts, a homogeneous mixture has to be created.
However, due to their polarity, water and fat do not mix spontaneously. There
are several ways to solve this problem, but adding an emulsifier is the simplest
one.
Emulsifiers are chemical compounds belonging to a major category of chemi-
cals named as surfactants. Surfactants are organic molecules with amphipathic
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characteristics. Due to this fact, the molecules of the emulsifier can interact
either with polar and non-polar molecules. Therefore, the addition of an emul-
sifier, to a mixture of water and fat, allows the non-polar lipids to disperse into
the polar molecules of water [46].
Due to their different densities, water and fat tend to separate. An easy way to
avoid this is to add a stabilizer to the emulsion. Two major types of stabilizers
are available: solid phase stabilizers and liquid phase stabilizers. Solid phase
stabilizers work by creating a cross-linked matrix that traps the components
and avoid the separation. Liquid phase stabilizers increase the viscosity of the
emulsion thereby preventing the separation [46]. It should be stressed that even
with the stabilizer, the separation continues to take place, but very slowly.
Emulsions: choice of chemical compounds
Oil:
There are several vegetable oils which may be used in the phantom construction.
The choice of the oil was based on several factors, namely chemical composition,
toxicity, availability and price. Table 2.1 summarizes the information for four
different oils.
Table 2.1: Fatty acids in the composition of four different vegetal oils. The toxicity, price and
availability were also indicated.
One property of interest is the oil similarity to human fat in terms of fatty acid
composition. To perform this comparison, a study by Kokatnur et al. (1979)
was taken as reference [47]. In this study, the authors conduct an evaluation
of the major fatty acids that are present in fat of the human buttock and in
perirenal tissues. The relevant results are expressed in table 2.2.
In table 2.2, some fatty acids (myrist and palmitoleic acids) are neglected, since
their percentage is minimal when compared with other fatty acids and they
are not present in vegetable oils. In addition, focus was only to the perirenal
because of its anatomical proximity to the liver. Comparing tables 2.1 and 2.2,
we observe that peanut oil shows more proximity to human fat than any of the
Chapter 2. Material and Methods 29
Table 2.2: Fatty acid composition of fat in the perirenal region for different races and ages.
Adapted from [47]
other oils. It is commonly used in cooking and can be purchased from any food
store at a relatively low price. Furthermore, peanut oil has been previously
used in phantoms from other research groups thus providing more information
about its use in phantom construction [38, 45]. Taking all this into account,
peanut oil emerged as an optimal choice.
Emulsifier:
As emulsifier agent we used the anionic surfactant sodium dodecyl sulphate
(SDS). SDS is non-toxic and it was readily available.
Stabilizer:
Based on the literature two stabilizers were considered: agar and gelatine. Gela-
tine (solid phase stabilizer) is a triplex helix compound derived from hydrolysed
collagen and when in contact with water forms a gel which prevents phase sep-
aration [48]. Agar is a polysaccharide extracted from red-purple marine algae
and is used as a growing medium [49]. Gelatine was chosen over agar due to its
capacity to easily crosslink the amine groups by an aldehyde [48]. Formaldehyde
was the chosen aldehyde for this purpose.
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Preparation
Table 2.3: Composition and final volume of each vial.
A protocol, based on the report from Parlato et al. (2009) was designed in
order to prepare the emulsion and build the phantom:
1) The amount of each component of the emulsion was calculated in a Mi-
crosoft Excel spread sheet. The major parameters to consider here were
the volume of the vials and desired fat percentage. The composition of
each vial is given in table 2.3;
2) The desired volumes of water, oil and formalin were measured; gelatine
and emulsifier were weighted;
3) A 100mL solution of sodium dodecyl sulphate was prepared;
4) The gelatine was added while the solution was heating using a magnetic
stirrer hotplate [50];
5) When the solution reached a temperature between 65o − 93o the peanut
oil was added;
6) The mixture was then left to cool down and when it reached a temperature
between 37o − 49o, formalin was added;
7) The emulsion was homogenised, by means of a homogenizer, during 2
minutes with 1 minute rest interval;
8) Finally, the emulsion was rapidly cooled in ice in order to form a gel and
prevent phase separation.
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This procedure was repeated 6 times; one for each vial.
After all emulsions were prepared, the vials were placed side by side on a frame.
Figure 2.6 sketches the phantom final result, indicating the values of FF in each
vial.
Figure 2.6: Schematic representation of the phantom. Values of FF are shown within each vial.
2.2.3.2 Phantom measurements
The phantom was imaged in a 3T whole-body MRI scanner (Siemens Magnetom
Trio, Erlangen, Germany), using a ME-GRE sequence with 12 TEs. Further
imaging parameters were: FOV = 165 × 220mm, TR = 32ms, α = 10o,
Acquisition Matrix= 192 × 115 , 2 slices 10mm thick. Magnitude and phase
images were acquired with 5 different combinations of TE values:
1) Clinical protocol: TEs of 2,46ms to 15,99ms in increasing steps of 1.23ms;
2) TEs of 3,00ms to 28,3ms in increasing steps of 2,30ms;
3) TEs of 2.60ms to 16,46ms in increasing steps of 1,26ms;
4) TEs of 3,00ms to 27,20ms in increasing steps of 2,20ms;
5) TEs of 2,80ms to 28,10ms in increasing steps of 2,30ms.
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Image processing
Phase images were exported from the MR scanner in dicom format, where phase
values were integers ranging from -2048 to 2048. When these images are loaded
into a dicom reader, the image intensity, I, is rescaled according to:
I = RescaleSlope× Iraw +RescaleIntercept (2.11)
Where RescaleSlope and the RescaleIntercept are two main fields in any dicom
header. For Siemens scanners, the value of these fields is 2 and -4096 respec-
tively. When re-scaling takes place, phase values, from 0 to 4096, correspond
to real values falling in the interval [0, 2pi]. Phase values are wrapped, with the
instantaneous phase values, φ(t), confined to be in [−pi, pi] or [0, 2pi]. Therefore,
all phase values that are outside these intervals are folded back. In order to
surpass this problem and determine the correct phase values, the application of
phase unwrapping algorithms is needed.
Major steps for phase image pre-processing:
1) Scale image intensity according to 2.11 using Matlab;
2) Conversion of phase images from dicom to nifti format [51], using dcm2nii
utility [52];
3) Application of the rescaling using FSL [53];
4) Creation of a mask containing only the pixels within the vials. Mask
magnitude images using FSL’s Bet ;
5) Phase unwrapping using FSL’s prelude.
Images were then processed using the program described in section 2.2.2. Over
each vial, a region of interest (ROI) was defined where FF quantification was
performed and results were obtained as parametric maps. In addition, plots of
the true FF against the estimated FF were also obtained.
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2.2.3.3 In-vivo experiments
In order to perform in-vivo experiments, the Diamarker project population,
consisting of 37 controls (23 females, mean age of 49±7) and 32 patients (20
females, mean age of 60±8), was considered. The patient group is composed by
subjects with type II diabetes, while control group consists of subjects without
history of neuropsychiatric, renal, liver, heart, ocular or any other severe non-
age related disease. From this population seven controls and seven patients were
enrolled in our study. Control subjects were chosen with the prior information
that no liver fat accumulation was observed. In opposition, the chosen patients
were known to have considerable fat accumulation.
Prior to the present work, breath-hold images were acquired on a whole-body
MRI scanner (Siemens Magnetom Trio, Erlangen, Germany) using ME-GRE se-
quences with twelve echoes and acquisition parameters: FOV = 400× 400mm,
TR of 30ms and clinical protocol TEs. In this procedure, a single slice 10mm
thick, was acquired.
Fat quantification was performed for 7 controls and 7 patients. Only magnitude
models were used for this purpose, since no phase images had been acquired.
For each image, a mask was applied on the actual abdominal structures (ROIs),
as a means to discard the background noise. Finally, all results were obtained in
a form of parametric maps of the abdominal region and representing FF values
on a voxel-by-voxel basis.
Chapter 3
Results
3.1 Simulations studies
3.1.1 Noise studies
The variation of NSA with TE-∆TE, for magnitude and complex models, is
displayed in figure 3.1 for a RNA of 5%.
Figure 3.1: NSA values obtained with magnitude single- and dual-decay model (above). NSA
values for complex single- and dual-decay model (below). All values of NSA computed for a FF of
5% and a RNA of 5%.
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Figure 3.2: FF estimation error for magnitude (left) and complex (right) model. Both models were
implemented with dual-decay constants, FF equal to 5% and RNA of 5%. The error corresponding
to the TE-∆TE combination that is used in the clinical protocol is indicated with a black arrow.
From the comparison of the colour maps in figure 3.1, it becomes evident that
magnitude model is more sensitive to the assumptions that are considered for T ∗2
relaxation constants: generally, NSA values above 1 for single-decay model and
below 1 otherwise. In opposition, the complex model has higher NSA values:
generally, above 2 when implemented with dual-decay constants and below 2
otherwise. Hence, the fitting performed with single-decay constants appears to
be more robust to noise in both models. The clinical TE-∆TE combination is
indicated. This combination is not optimal, falling in a region where NSA is
not maximized. Furthermore, the results for a RNA of 10% (not shown) are
similar.
The colour maps in figure 3.2 show the dependence of FF estimation error on the
combinations of TEs that are used to sample the signal, for both magnitude
and complex models, implemented with dual-decay constants. In the dual-
decay model, T ∗2water and T
∗
2fat are different, whereas in the single-decay model
the simplification T ∗2water=T
∗
2fat is considered. A straightforward observation,
which is common to all other parameter combinations that were used in the
simulations, is that there are combinations of TE which yield a lower error
associated with FF estimation -TE-∆TE best combinations.
Figure 3.3 extends the results for different values of FF (25%, 50%, 75%). The
number of TE-∆TE combinations that minimize FF error increase with the
value of FF. The performance of the complex model is better than that of the
magnitude model since overall, the error in FF is smaller than that obtained
with the magnitude model: almost all errors are below 10% for all FF.
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Figure 3.3: FF estimation error for magnitude (above) and complex (below) model. Both models
were implemented with dual-decay constants, FF equal to 5% and RNA of 5%.
Figure 3.4: FF estimation bias for different values of FF, performed with magnitude (above) and
complex (below) models, dual-decay constants and RNA of 5%.
Results of the estimation bias are shown in figure 3.4. Similarly to the FF esti-
mation error, also here the complex model performs better than the magnitude
model. For all FF values above 5%, minimum estimation bias obtained with
the complex model lie close to 0% whereas for the magnitude models that is
not the case. For a FF of 5%, both models fail to yield unbiased estimations of
FF.
Figure 3.5 shows a comparison between the performances of complex and mag-
nitude models using single-decay constants. When comparing figures 3.3 and
3.5 one observes that the way by which relaxations effects are included in the
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model strongly affect the FF estimation error. Particularly for the magnitude
model, considering T ∗2water=T
∗
2fat decreases the estimation error for all FF val-
ues except that of 5%. In general, the complex model performs better than the
magnitude model, even for FF=5% where complex dual-decay model achieves
lower error. Finally, complex model appears to be more robust, in terms of the
estimation error, when implemented with two decay constants.
Figure 3.5: FF estimation errors for different values of FF, estimated with magnitude (above)
and complex (below) models with single-decay constants. RNA of 5%.
The bias obtained for the magnitude single-decay model is shown in figure 3.6.
When compared to figure 3.4, we observe that magnitude single-decay model
originates a more biased estimation of FF. However, for FFs of 50%, magnitude
model presents some regions of bias between -10% and 10%. The problem here is
that it is difficult to find a TE-∆TE combination where both FF error and bias
are minimized. The bias results for complex model are not represented since
their values are generally negative and extremely high, lying beyond -100%.
This is an unexpected result, which illustrates some difficulties of the complex
in describing the data when implemented with only one decay constant.
Figure 3.6: FF estimation bias for different values of FF, estimated with magnitude single-decay
model and RNA of 5%.
It is worth mentioning that, in all cases, the TE-∆TE combination that is used
in the clinical protocol falls on regions of high errors and biases. This suggests
that the clinical protocol is not optimized for FF estimation.
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The error and bias associated with T ∗2 constants (results not shown) indicate
that the single-decay magnitude model performs better than the dual-decay
magnitude model. For low values of FF (5% and 25%), the error and bias in
the estimates of T ∗2fat are high and more TE-∆TE combinations are observed
to minimize the error and bias of T ∗2water. In contrast, for high values of FF
(75%) the opposite is observed: lower error and bias for T ∗2fat and higher error
and bias for T ∗2water. The complex model shows a similar behaviour. In fact, for
low values of FF, the complex single-decay model is better, but as the values of
FF increase, the dual-decay model yields more TE-∆TE combinations in which
the error and bias are minimized.
From the previous results, four alternative TE combinations were chosen to
minimize the errors and biases, particularly in FF, associated with each model.
Table 3.1 indicates these combinations.
Table 3.1: Alternative TE-∆TE combinations for magnitude and complex models with single-
and dual-decay constants.
The choice of the values in 3.1 relied on the identification of TE-∆TE regions
where the error and bias associated with T ∗2water, T
∗
2fat and FF respectively were
minimized. However, this implies that there are a total of six parameters that
must be accounted for. This means that the chosen TE-∆TE combinations are
a compromise between the minimization of ErrorT ∗2water , ErrorT ∗2fat , ErrorFF ,
BiasT ∗2water , BiasT ∗2fat and BiasFF . Tables 3.2 and 3.3 summarize the biases
and errors in the various parameters associated with the chosen combinations.
Tables 3.4 and 3.5 present the same information for the clinical protocol.
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3.1.2 Influence of magnetic field inhomogeneities and
noise on FF estimation using complex model
Figures 3.7 and 3.8 illustrate the complex model behaviour under the influence
of B0 inhomogeneities for different TEs combinations. Our results demonstrate
that in the presence of magnetic field inhomogeneities (in the plots expressed as
off-resonance, ∆F0, in Hz), the estimation of all parameters and that of FF in
particular, are highly biased. For the remaining FF values (results not shown),
a similar behaviour is observed. However, complex dual-decay model appears
to be slightly more resilient to phase errors: low bias is achieved even for high
off-resonance frequencies, particularly for low FFs .
Figure 3.7: Influence of magnetic field inhomogeneities on FF, T ∗2water and T
∗
2fat bias for single-
and dual-decay complex models. Simulation parameters: FF=75% for single- and decay-model
using the alternative protocol.
Figure 3.8: Influence of magnetic field inhomogeneities on FF, T ∗2water and T
∗
2fat bias for single-
and dual-decay complex model. Simulation parameters: FF=75% for for single- and decay-model
using the clinical protocol
The influence of noise and magnetic field inhomogeneities in FF estimation is
illustrated in figures 3.9 (Error) and 3.10 (Bias) for the dual-decay model and
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considering TE-∆TE values that according to table 3.1 minimize both FF bias
and error in the presence of noise only.
Figure 3.9: FF estimation error in the presence of noise and magnetic field inhomogeneities on
complex dual-decay model. TEmin of 2.80ms.
Figure 3.10: FF estimation bias in the presence of noise and magnetic field inhomogeneities on
complex dual-decay model. TEmin of 2.80ms.
In figures 3.9 and 3.10 it is notorious that in the presence of both magnetic
field inhomogeneities and noise, the performance of the complex model becomes
clearly worse. This is translated into high values of FF bias and error for off-
resonance frequencies.
3.2 Phantom measurements
Figure 3.11 shows the phantom that was built to test the simulation results in
a controlled setting. Visual inspection as well as the MR images suggested that
the emulsions in all tubes were homogeneous, at least at a macroscopic scale.
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Figure 3.11: Phantom for FF quantification with indication of the relative amount of fat per vial.
3.2.1 Clinical protocol
Figure 3.12 shows a phantom coronal image acquired using the clinical proto-
col. FF quantification with the magnitude model with single- and dual-decay
constants is represented as parametric maps. Moreover, a plot of the true FF
against the estimate FF, computed as the average estimated FF in each vial,
is also shown for clarity.
Figure 3.12: Phantom FF quantification with the magnitude model implemented with both single-
and dual-decay constants. Coronal image of the phantom, obtained with the clinical protocol (A),
parametric map of FF (B) and plot of the true FF against the estimated FF (C).
We observe that for both magnitude single- and dual-decay models a good es-
timation for low FF (0% and 5%) as well as for a FF of 100% is obtained. For
intermediate values, the estimation of FF in the vials is more biased. Never-
theless, for FF=50% the estimated FF value (single-decay model) is very close
to its true value but, with a high associated error. The comparison of figure
3.12 with the same results for another coronal slice (results not shown) shows
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that there is a disparity FF estimation from one slice to another (especially for
the dual-decay model). This observation may indicate the presence of emulsion
inhomogeneities along the vials, which in turn may reduces the sample quality
leading to less accurate estimations. The magnitude dual-decay model appears
to be more sensitive to such problem.
Figure 3.13: Phantom FF quantification performed with complex model, implemented with both
single- and dual-decay constants. Acquired magnitude (A) and phase (B) images of a slice using
the clinical protocol, parametric map of FF quantification (C) and plot of the true FF against the
estimated FF (D).
The FF was also estimated using the complex model with single- and dual-decay
constants. The result for a coronal slice is presented in figure 3.13.
Complex models show a less accurate quantification. Interestingly, though, the
errors associated with each of estimations are smaller than those of the mag-
nitude model, the majority of our estimates are underestimated, particularly
for the single-decay model. This observation is in contradiction to the simula-
tion results: although, theoretically best results are obtained using the complex
models, the same is not truth in practical approaches.
3.2.2 Magnitude model alternative combinations
From section 3.1.1, two alternative combinations were chosen and known to
minimize the error and bias in the magnitude model. These combinations were
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tested using the phantom and results are shown in figures 3.14 and 3.15 for two
distinct coronal slices.
Figure 3.14: Phantom FF quantification of images from two different slices using the alternative
combination for the magnitude single-decay model.
Figure 3.15: Phantom FF quantification of images from two different slices using the alternative
combination for the magnitude dual-decay model.
Figure 3.14 illustrates that FF estimation is, in general, affected by a large bias.
Interestingly, from the comparison with figure 3.12, the precise estimation of
the FF in the vial with an emulsion of 50% fat must be stressed.
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Results obtained with the alternative TE-∆TE combination for magnitude
dual-decay model is presented in figure 3.15. In contrast with the clinical pro-
tocol acquisition, figure 3.15 shows a more robust estimation, particularly for
low values of FF. Associated with this quantification, it is noteworthy the low
FF errors, in opposition with the magnitude single-decay model.
3.2.3 Complex model alternative combinations
Results obtained with alternative TE-∆TE combinations are expressed in fig-
ures 3.16 and 3.17.
Figure 3.16: Phantom FF quantification of images from two different slices acquired using the
alternative combination for the complex single-decay model.
Results show a severe disparity from the true amount of FF. Similarly to the
clinical protocol, the present quantification shows values mainly below the true
values. In addition, the quantification disparity from slice to slice is even larger
than in the case of the magnitude models, particularly in the case of dual-decay
model.
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Figure 3.17: Phantom FF quantification of images from two different coronal slices acquired using
the alternative combination for the complex dual-decay model.
3.3 In-vivo Studies
Figure 3.18 shows the parametric maps obtained for FF quantification in the
liver for 3 controls using the magnitude model with single- and dual-decay con-
stants. Results suggest that the magnitude single-decay model is very accurate
to estimate low FF values. In fact, all parametric maps obtained with this model
show a liver fat accumulation inferior to 10% (FF threshold for steatosis). On
the contrary, magnitude dual-decay model systematically fails to correctly sort
out the signal intensity of water and fat. In that sense, voxels where the FF is
close 0% are wrongly associated with a FF close to 100%. Similarly, voxels in
the subcutaneous fat are wrongly associated with a FF of 0%.
Figure 3.19 shows FF parametric maps of three patients obtained with the
magnitude model. As for the controls, here, magnitude single-decay model also
performed better in estimating FF values. In additions, magnitude dual-decay
model continues to incorrectly overestimate FF values.
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Figure 3.18: Parametric maps of liver FF in three control subjects obtained with the magnitude
model.
Figure 3.19: Parametric maps of liver FF in three patient obtained with the magnitude model.
Chapter 4
Discussion
The goal of the present work was to optimize the acquisition strategy for FF
quantification in the liver. The approach that was followed consisted in:
1) Study the dependence of FF quantification error and bias on distinct TE-
∆TE combinations both for magnitude and complex models;
2) Find alternative TE-∆TE combinations for FF quantification and test
their robustness experimentally;
3) Compare with the standard clinical protocol.
Simulation results indicate that TE-∆TE combinations have a strong influence
in the FF estimation error. Overall, different TE-∆TE combinations optimize
FF quantification for different conditions. In fact, results show that TE-∆TE
combinations which minimize the errors and biases in one model, not necessarily
do the same in other models (e.g. figure 3.3). Moreover, distinct TE-∆TE com-
binations minimize different estimation parameters, which implies that there is
not a single optimal TE-∆TE combination to estimate FF with minimum error
and bias.
FF estimation with the magnitude model is more sensitive to noise [4, 37], es-
pecially when considering dual-decay relaxation constants. In the presence of
noise and particularly for low values of FF, this model may lead to an over-
estimation of the true amount of fat as can be clearly observed in figure 3.4.
The sensitivity of the magnitude model to the presence of noise is explained by
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the fact that magnitude images amplify the noise that is present in the com-
plex data acquired in the scanner. In fact, the square operation on complex
data transforms and amplifies the noise with Gaussian distribution into noise
with Rician distribution. In addition, the sensitivity of the magnitude model
to noise is also due to the fact that it discards the phase information that is
available in the data. As a consequence this model is not able to distinguish
the major component in the voxel. This becomes evident in the in vivo-studies,
where the magnitude dual-decay model systematically estimates high FF in
controls known to have a low FF. Another consequence of the lack of phase
information is that the estimations for FF near 50% are strongly dependent on
the TE-∆TE combination that is used to sample the signal. This is explicitly
demonstrated in the bias colour maps (figures 3.4 and 3.6) where an intricate
pattern of higher and lower biases is observed. In contrast, complex model ex-
hibits a more robust fitting, achieving higher values of NSA and lower errors,
especially for dual-decay constants. For both magnitude and complex models,
results demonstrate that as the values of FF increase, more TE-∆TE combina-
tions, where FF error and bias are minimized appear. This is the result of the
increased signal intensity from fat protons as FF values increase.
The way relaxations effects are included in the model influence the FF estima-
tion [4, 7]. Magnitude model profits from considering a single-decay constant
for water and fat, whereas complex model appears to perform better considering
two different relaxation constants. The justification for this lies in the fact that
the complex model with dual-decay constants is a more realistic description of
the data than any other model. This is proved by the low FF bias and errors
that are obtained, especially for higher values of FF.
The studies regarding magnetic field inhomogeneities indicate that complex
model leads to a highly biased FF estimations for off-resonance frequencies.
This is enhanced in figure 3.7 in which, even for optimized TE-∆TE combina-
tions, minimization is only achieved for frequencies very close to the resonance
frequency. Simulation results shows that, in the presence of the cumulative
effects of phase errors and noise, the complex model may show difficulties per-
forming fat quantification.
Finally, simulation results demonstrated that the clinical protocol is not opti-
mized for FF quantification. Generally, the clinical TE-∆TE combination falls
on regions of larger errors, which may lead to incorrect estimations.
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In the development of a new strategy for image acquisition, several considera-
tions were made in order to properly identify alternative TE-∆TE combinations
from the simulation studies. Finding the best TE-∆TE combination that si-
multaneously minimizes the bias and errors associated with all the parameters
(T ∗2water, T
∗
2fat, and FF), is difficult. The problem here is that a TE-∆TE com-
bination which optimizes a parameter may also dramatically increase the error
and bias in others. Therefore, the choice was to consider TE-∆TE combinations
that would roughly optimize the error and bias in FF, while keeping TEmin and
TE-∆TE as small as possible in order to maximize image SNR. Finally, there
were hardware limitations: the whole-body MRI scanner does not allow first
TEs and ∆TEs lower than 2.40ms and 1.26ms, respectively.
Phantoms experiments emphasise the limitations of the clinical protocol to cor-
rectly estimate certain amounts of fat. Although magnitude single-decay model
shows accurate estimates for certain values of FF (0%, 5% and 100%) it also
shows weak estimations for FFs between 5% and 100%. The better quantifica-
tion of low FF values in phantoms using the clinical protocol contradicts the
simulation results. In phantom experiments, differences in FF estimations for
different coronal slices are observed. This suggests that although, the emulsions
appears to be homogeneous at a macroscopic scale, that is probably not so at
a microscopic level. Furthermore, as the amount of FF increases more inhomo-
geneities may be present in the emulsions, which can reduce sampling quality
leading to more incorrect estimations. The magnitude dual-decay model also
shows an inaccurate quantification of fat, with the majority of the estimates
lying below the true value of FF.
When the FF is estimated using the alternative TE-∆TE combinations, im-
provements are found in the magnitude model. It is noteworthy the precise
estimation of FF of 50% using magnitude single-decay model where the FF
error is almost zero. This observation is in support of our simulation data
and emerges as results of our optimization process (table 3.2). Magnitude
dual-decay model also expresses enhanced performance in low FF range, being
capable of estimating FF of 0%, 5%, 10% more accurately, but failing in esti-
mating FF=100%. Nevertheless, we observed that in both models, an unbiased
estimation of the FF in a given vial often corresponds to the biased estima-
tion of FF in other vials, which provide further evidence of the difficulties in
choosing a single TE-∆TE combination that minimizes all FF simultaneously.
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For the complex model, alternative TE-∆TE combinations with lower error and
bias compared to magnitude model were identified. Nevertheless, even for these
alternative TE-∆TE combinations, the complex model often fails the FF esti-
mation, which implies that the drawbacks associated with the complex model
such as the presence of phase errors may be determinant in practice.
In-vivo experiments, using the clinical protocol and the magnitude single-decay
model show that it can correctly identify subjects with small amounts of liver
fat as opposed to patients with steatosis. However, it also shows how it fails to
correctly estimate the FF in subcutaneous fat. This implies that its use in situ-
ations where image SNR is lower may originate problems in FF quantification.
This work presents some limitations. In the first place, the fact that the emul-
sions of our phantom may not be totally homogeneous is a confounding effect
in the interpretation of these results. However, obtaining homogeneous emul-
sions of water and fat is extremely difficult. For instance, the preparation of a
macroscopically homogeneous emulsion with FF=75% was not possible. This
work also leads to several important conclusions. It is demonstrated that new
acquisition protocols can be developed to improve FF quantification. This is
particularly important for magnitude model, which is commonly used in clin-
ical procedures. It is also demonstrated that an optimal model or TE-∆TE
combinations to perform FF quantification does not exist, but rather better
options for different situations. Therefore, when developing a complete acqui-
sition protocol for FF quantification, a compromise between distinct TE-∆TE
combinations, different models and the expected range of FFs will have to be
taken into account. Finally, the complex model with dual-decay constants to-
gether with the appropriate changes in the pulse sequence in order to minimize
the effects of phase errors, may emerge as the best solution to improve FF
quantification
Chapter 5
Conclusion
In the present work the problem of liver fat quantification using chemical shift
imaging, was investigated with a view at data acquisition optimization at 3T.
The effects of noise, phase errors, relaxation effects and especially the influence
of distinct TE-∆TE combinations, so far largely overlooked in the literature, in
FF estimation, were evaluated for four distinct models.
In our approach, we demonstrated, theoretically, that good FF estimations
can be obtained, suggesting that enhanced fat quantification can be performed
by means of correctly choosing the TE-∆TE combinations. Moreover, it was
shown that better FF estimations are obtained for the complex model that is
potentially more precise in determining the FF because it describes the data
with more completeness. However, the potential advantages of the complex
model are largely overshadowed by the inaccuracies that are introduced by
phase errors, in the presence of magnetic field inhomogeneities. Since the latter
are more prominent at high field strength (3T and above), attention should be
given to pulse sequence optimization to minimize phase errors.
We also demonstrate that the problem of FF estimation from ME-GRE im-
ages is not a straightforward procedure and involves several complexities, at
both image acquisition and image post-processing levels. The standard clinical
protocol, based on the magnitude model, has several flaws and needs improve-
ment. Nevertheless, we demonstrate that the standard clinical can be used as
way to perform early steatosis staging: which may allow us to constrain ranges
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of FFs. This fact in association with new enhanced FF quantification proto-
cols, can emerge as a possible way to develop a complete new strategy for fat
quantification using chemical shift imaging.
5.1 Future Work
The development of a complete user interface for the application that was de-
veloped to quantify liver FF on voxel-by-voxel basis is the next step to extend
FF quantification to clinical routine. Finally, the acquisition of in vivo phase
images is of great importance to address the performance of the complex model
in-vivo. Furthermore, pulse sequence optimization will be carried-out in order
to minimize the effects of phase errors on FF quantification using the complex
model.
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